Zomedica Announces Up to $10 Million Private Offering of Common Shares
May 15, 2018 16:01 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 15, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (the "Company"), a veterinary diagnostic and pharmaceutical company, today announced...
Zomedica Signs Agreement With Seraph Biosciences for Innovative Veterinary Point-of-Care Diagnostic
May 10, 2018 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM), a veterinary diagnostic and pharmaceutical company, today announced it has entered...
Zomedica to Present at 2018 Disruptive Growth & Healthcare Conference
May 07, 2018 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 07, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will...
Zomedica to Present at 30th Annual ROTH Conference
March 07, 2018 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., March 07, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will...
Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results
February 28, 2018 16:11 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit
February 20, 2018 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform
December 21, 2017 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Zomedica Announces Achievement of Therapeutic Development Milestones
December 12, 2017 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Zomedica Pharmaceuticals Corp. Registration Statement Declared Effective by U.S. Securities and Exchange Commission
November 20, 2017 18:51 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (NYSE American:ZOM) (Zomedica or the Company), a veterinary pharmaceutical and health care solutions...
Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017
November 16, 2017 09:12 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions...